Search Results - Frosig, Thomas Morch

  • Showing 1 - 9 results of 9
Refine Results
  1. 1
    HLA-Restricted CTL That Are Specific for the Immune Checkpoint Ligand PD-L1 Occur with High Frequency in Cancer Patients

    HLA-Restricted CTL That Are Specific for the Immune Checkpoint Ligand PD-L1 Occur with High Frequency in Cancer Patients by MUNIR, Shamaila, GITTE HOLMEN ANDERSEN, MET, Ozcan, DONIA, Marco, THOMAS MORCH FRØSIG, STINE KIAER LARSEN, TOBIAS WIRENFELDT KLAUSEN, INGE MARIE SVANE, MADS HALD ANDERSEN

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Comment on ＂5-Azacytidine Promotes an Inhibitory T-Cell Phenotype and Impairs Immune Mediated Antileukemic Activity

    Comment on ＂5-Azacytidine Promotes an Inhibitory T-Cell Phenotype and Impairs Immune Mediated Antileukemic Activity by Frosig, Thomas Morch, Hadrup, Sine Reker

    Get full text
    Items that this one cites
    Article
    Save to List
    Saved in:
  3. 3
    Characterization of T-cell responses against IκBα in cancer patients

    Characterization of T-cell responses against IκBα in cancer patients by Munir, Shamaila, Frøsig, Thomas Mørch, Hansen, Morten, Svane, Inge Marie, Andersen, Mads Hald

    Published in Oncoimmunology
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 4
    Broadening the repertoire of melanoma-associated T-cell epitopes

    Broadening the repertoire of melanoma-associated T-cell epitopes by Frøsig, Thomas Mørch, Lyngaa, Rikke, Met, Özcan, Larsen, Stine Kiær, Donia, Marco, Svane, Inge Marie, thor Straten, Per, Hadrup, Sine Reker

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  5. 5
    Design and validation of conditional ligands for HLA‐B08:01, HLA‐B15:01, HLA‐B35:01, and HLA‐B44:05

    Design and validation of conditional ligands for HLA‐B08:01, HLA‐B15:01, HLA‐B35:01, and HLA‐B44:05 by Frøsig, Thomas Mørch, Yap, Jiawei, Seremet, Tina, Lyngaa, Rikke, Svane, Inge Marie, Thor Straten, Per, Heemskerk, Mirjam H. M., Grotenbreg, Gijsbert M., Hadrup, Sine Reker

    Published in Cytometry. Part A
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    Cryopreservation of MHC multimers: Recommendations for quality assurance in detection of antigen specific T cells

    Cryopreservation of MHC multimers: Recommendations for quality assurance in detection of antigen specific T cells by Hadrup, Sine Reker, Maurer, Dominik, Laske, Karoline, Frøsig, Thomas Mørch, Andersen, Sofie Ramskov, Britten, Cedrik M., van der Burg, Sjoerd H., Walter, Steffen, Gouttefangeas, Cécile, Karpus, William J.

    Published in Cytometry. Part A
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  7. 7
    Tryptophan 2,3-dioxygenase (TDO)-reactive T cells differ in their functional characteristics in health and cancer

    Tryptophan 2,3-dioxygenase (TDO)-reactive T cells differ in their functional characteristics in health and cancer by Hjortsø, Mads Duus, Larsen, Stine Kiaer, Kongsted, Per, Met, Özcan, Frøsig, Thomas Mørch, Andersen, Gitte Holmen, Ahmad, Shamaila Munir, Svane, Inge Marie, Becker, Jürgen C, Straten, Per thor, Andersen, Mads Hald

    Published in Oncoimmunology
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  8. 8
    Establishing the pig as a large animal model for vaccine development against human cancer

    Establishing the pig as a large animal model for vaccine development against human cancer by Overgaard, Nana H, Frøsig, Thomas M, Welner, Simon, Rasmussen, Michael, Ilsøe, Mette, Sørensen, Maria R, Andersen, Mads H, Buus, Søren, Jungersen, Gregers

    Published in Frontiers in genetics
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  9. 9
    Design and validation of conditional ligands for HLA‐B 08:01, HLA‐B 15:01, HLA‐B 35:01, and HLA‐B 44:05

    Design and validation of conditional ligands for HLA‐B 08:01, HLA‐B 15:01, HLA‐B 35:01, and HLA‐B 44:05 by Frøsig, Thomas Mørch, Yap, Jiawei, Seremet, Tina, Lyngaa, Rikke, Svane, Inge Marie, Thor Straten, Per, Heemskerk, Mirjam H. M., Grotenbreg, Gijsbert M., Hadrup, Sine Reker

    Published in Cytometry. Part A
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: